Intuitive Surgical Inc. Common Stock (ISRG)
Stock · NASDAQ · Health Care
$426.91as of 10/16/2026
Price chart
Active signals
ISRG Signal Track Record
How signals performed across all stocks →What ISRG's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 32 | +3.4% | 66% | September 4, 2026 |
| Bollinger Band Breakout | 24 | +3.9% | 67% | September 18, 2026 |
| Bollinger Band Breakdown | 22 | +0.7% | 59% | September 8, 2026 |
| 200-Day Moving Average TouchActive now | 9 | +5.2% | 67% | June 24, 2025 |
| Any 20-session window (baseline) | +0.7% | 53% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About ISRG
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into…
- Sector
- Health Care
- Industry
- Industrial Specialties
- Employees
- 17,021
Fundamentals
- 1-day range
- $419.54$429.89
- Market cap
- $132.02B
- P/E (trailing)
- 47.42
- P/E (forward)
- 35.34
- EPS (trailing)
- $8.73
- Dividend yield
- —
- Beta
- 1.46
- Avg. volume
- 2.77M
How Intuitive Surgical Inc. Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Feb 3, 2026 · via SEC EDGAR / Finnhub
Forecasts
30 analyst ratings
Intuitive Surgical Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- ISRGIntuitive Surgical Inc. Common Stock$426.7▼ 0.27%Market cap $132.02BP/E 47.42$328.57$603.88
- STESTERIS plc (Ireland) Ordinary Shares$222.66▼ 0.74%Market cap $22.62BP/E 27.15$195.14$269.44
- ZBHZimmer Biomet Holdings Inc. Common Stock$94.98▲ 0.64%Market cap $18.80BP/E 22.28$79.12$106.88
- MASMasco Corporation Common Stock$72.87▲ 0.40%Market cap $14.88BP/E 15.88$58.16$83.64
- AITApplied Industrial Technologies Inc. Common Stock$330.48▼ 1.00%Market cap $13.27BP/E 29.52$238.72$374.8
- SNNSmith & Nephew SNATS Inc. Common Stock$29.06▼ 0.10%Market cap $12.61BP/E 18.34$980.4$1,427
- ALGNAlign Technology Inc. Common Stock$147.31▼ 1.36%Market cap $12.11BP/E 25.36$126.33$200.44
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| ISRG Intuitive Surgical Inc. Common Stock | $132.02B | 47.42 | $426.7 | ▼ 0.27% | $328.57$603.88 |
| STE STERIS plc (Ireland) Ordinary Shares | $22.62B | 27.15 | $222.66 | ▼ 0.74% | $195.14$269.44 |
| ZBH Zimmer Biomet Holdings Inc. Common Stock | $18.80B | 22.28 | $94.98 | ▲ 0.64% | $79.12$106.88 |
| MAS Masco Corporation Common Stock | $14.88B | 15.88 | $72.87 | ▲ 0.40% | $58.16$83.64 |
| AIT Applied Industrial Technologies Inc. Common Stock | $13.27B | 29.52 | $330.48 | ▼ 1.00% | $238.72$374.8 |
| SNN Smith & Nephew SNATS Inc. Common Stock | $12.61B | 18.34 | $29.06 | ▼ 0.10% | $980.4$1,427 |
| ALGN Align Technology Inc. Common Stock | $12.11B | 25.36 | $147.31 | ▼ 1.36% | $126.33$200.44 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- If You Invested $1000 In Intuitive Surgical Stock 10 Years Ago, You Would Have This Much Todaybenzinga · 10/16/2026
- Intuitive Surgical, Inc. (ISRG) Exceeds Market Returns: Some Facts to ConsiderYahoo · 10/9/2026
- Robotics Stocks Diverge as AI and Semiconductor Automation Leaders Pull AheadChartMill · 10/9/2026
- Is Intuitive Surgical (ISRG) a Buy as Wall Street Analysts Look Optimistic?Yahoo · 10/8/2026
- The Monopolistic Razor-and-Blade Engine I Can’t Stop BuyingYahoo · 10/8/2026
- Intuitive Surgical (NASDAQ:ISRG) Combines Strong Growth With a Constructive Technical SetupChartMill · 10/8/2026
- 2 Profitable Stocks with Exciting Potential and 1 We QuestionYahoo · 10/8/2026
- Should Barclays’ Bullish Initiation Amid Rising Rivalry Require Action From Intuitive Surgical (ISRG) Investors?Yahoo · 10/8/2026
- Intuitive Surgical (ISRG) and JNJ Give Jim Cramer More Than Valuation to ConsiderYahoo · 10/7/2026
Insider Activity
Insider Actions →- Fredrik Widman · September 15, 2026 · Option Exercise543 @ $109.49
- Fredrik Widman · September 15, 2026 · Option Exercise546 @ $79.64
- Fredrik Widman · September 15, 2026 · Sale543 @ $374.44
- Fredrik Widman · September 15, 2026 · Sale546 @ $374.44
- Mark Brosius · September 11, 2026 · Sale25 @ $365.79
- Mark Brosius · September 10, 2026 · Sale23 @ $347.66
- Mark Brosius · September 9, 2026 · Sale23 @ $350.2
- Mark Brosius · September 8, 2026 · Sale46 @ $361.23
- Mark Brosius · August 21, 2026 · Sale77 @ $375.57
- Mark Brosius · August 20, 2026 · Sale77 @ $396.37
- Mark Brosius · August 19, 2026 · Sale77 @ $394.26
- Mark Brosius · August 18, 2026 · Sale77 @ $394
- Mark Brosius · August 17, 2026 · Sale77 @ $390.67
- Gary S. Guthart · August 11, 2026 · Sale10.0K @ $400
- Amy L. Ladd · August 11, 2026 · Sale72 @ $393.1
Institutional Ownership
March 31, 2026
- Total shares held
- 282.32M
- Total value held
- $121.83B
- Institutional holders
- 2255
- Unknown30.10M
- Unknown23.08M
- Unknown15.85M
- Unknown12.52M
- Unknown8.47M
- Unknown8.05M
- Unknown6.06M
- Unknown5.48M
- Unknown3.96M
- Unknown3.85M
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Intuitive Surgical Prepares for Q3 Earnings Amid Growth and Competition
Intuitive Surgical is approaching its Q3 earnings release, with analysts noting continued double‑digit revenue growth and expanding procedure volumes. At the same time, new robotic competitors are entering the market, prompting discussion of the company's current valuation multiples. The stock has shown strong price momentum, reflected in a relatively high RSI and recent touches near its 200‑day moving average.
Intuitive Surgical Prepares for Q3 Earnings Amid Growth and Competition. Intuitive Surgical is approaching its Q3 earnings release, with analysts noting continued double‑digit revenue growth and expanding procedure volumes. At the same time, new robotic competitors are entering the market, prompting discussion of the company's current valuation multiples. The stock has shown strong price momentum, reflected in a relatively high RSI and recent touches near its 200‑day moving average.